Skip to content
OpenCapital
Get started

Roivant Sciences ROIV Q3 2026 earnings

Reported February 6, 2026 · Before market open

Revenue$2.0MMiss by $3.1MDiluted EPS-$0.24Beat by $0.06
Revenue estimate$5.1M
EPS estimate-$0.30

Next report

Aug 10, 2026 (in a month)
Revenue estimate$2.1M
EPS estimate-$0.33

Versus estimates

Revenue

Q4 2026$2.5MMiss by $894.5K
Q3 2026$2.0MMiss by $3.1M
Q2 2026$1.6MMiss by $4.0MQ3 2025$9.0MMiss by $53.1MQ2 2025$4.5MMiss by $41.4MQ1 2025$55.1MBeat by $24.4M

Diluted EPS

Q4 2026-$0.36Miss by $0.10
Q3 2026-$0.24Beat by $0.06
Q2 2026-$0.28Beat by $0.04Q3 2025-$0.13Beat by $0.11Q2 2025-$0.29Miss by $0.04Q1 2025-$0.18Beat by $0.06

Ask the moment Roivant Sciences reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Roivant Sciences report Q3 2026 earnings?
Roivant Sciences (ROIV) reported Q3 2026 earnings on February 6, 2026 before market open.
What were Roivant Sciences's Q3 2026 revenue and EPS?
Roivant Sciences reported revenue of $2.0M and diluted EPS of $-0.24 for Q3 2026.
Did Roivant Sciences beat estimates in Q3 2026?
Revenue missed the consensus estimate of $5.1M by $3.1M. EPS beat the consensus estimate of $-0.30 by $0.06.
How did Roivant Sciences's Q3 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 77.8% from $9.0M a year earlier and diluted EPS declined 84.6% from $-0.13.
Where can I find Roivant Sciences's Q3 2026 SEC filings?
You can read the 8-K earnings release (0001635088-26-000009) and the 10-Q periodic report (0001635088-26-000011) directly on SEC EDGAR. The filing index links above go to sec.gov.